Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Neuropsychiatric Disease and Treatment|December 7, 2018
Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case reportBurak Kulaksızoğlu, Hüseyin Kara, Berkan Bodur, et al.
Nordic Journal of Psychiatry|October 8, 2013
Increased serum prolactin levels in drug-naive first-episode male patients with schizophreniaYakup Albayrak, Murat Beyazyüz, Elmas Beyazyüz, et al.
Alpha Psychiatry|November 25, 2022
The Relationship of Serum Leptin and Ghrelin Levels with Craving and Withdrawal in Opioid Use DisorderHüseyin Kara, Ali Erdoğan, Halide Akbaş, et al.
Turk Psikiyatri Dergisi = Turkish Journal of Psychiatry|August 27, 2011
Galactorrhea during duloxetine treatment: a case reportSevda Korkmaz, Murat Kuloğlu, Umut Işık, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 10, 2013
Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary studyYakup Albayrak, Cüneyt Ünsal, Murat Beyazyüz, et al.
Perceptual and Motor Skills|March 9, 2002
Color and number preferences of patients with psychiatric disorders in eastern TurkeyMurat Kuloğlu, Murad Atmaca, A Ertan Tezcan, et al.
Psychiatry Research|May 1, 2007
Neopterin levels and dexamethasone suppression test in obsessive-compulsive disorderMurat Kuloğlu, Murad Atmaca, Süleyman Onal, et al.
Human Psychopharmacology|September 17, 2021
Comparison of naltrexone implant and oral buprenorphine-naloxone in the treatment of opiate use disorderAli Erdoğan, Müge Topcuoğlu, Mustafa Nogay Coşkun, et al.
Clinical Neurology and Neurosurgery|August 4, 2009
A case study of neuro-psycho-Behçet's syndrome presenting with psychotic attackOrhan Deniz, Ali Cayköylü, Gönül Vural, et al.
Acta Neuropsychiatrica|July 15, 2016
Increased serum G72 protein levels in patients with schizophrenia: a potential candidate biomarkerEsra Soydaş Akyol, Yakup Albayrak, Nurkan Aksoy, et al.
Pageof 2